Signalling in the genomic era.
For a complex organism, short range signalling is not sufficient to coordinate the behaviour of all cells composing itself. The response to stimuli is the reprogramming of cell activity (resulting in differentiation, proliferation, stand by or apoptosis depending on the set of signals). Cells own elaborate and complex systems of proteins that enable them to communicate, including both secreted signalling molecules and related factors, deriving from relic mechanisms. The intra and intercellular signalling are actively studied not only to comprehend the basic mechanisms that allowed the evolution of mammals species on earth, but also because the alteration of one or more of these pathways is recognized to be involved in a crescent number of human diseases, both degenerative and tumoural. That is, a growing body of evidences suggest that every human disease may be analyzed and classified by a "signalling disease" point of view. This approach opens new therapeutic perspectives, virtually amplifying for every single disease the number of therapeutic targets (in terms of both genes and proteins) to upstream and/or downstream, short and/or long distance proteins interacting with the altered molecule, thus individuating many other targets to which act upon.
Department of Otorinolaringoiatria, Foniatria e Audiologia "G. Ferreri", University of Rome "Sapienza", viale del Policlinico, 155 - 00185 Rome, Italy.
Vincenza Rita
VR
Lo Vasco